Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immune Cell Therapy Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Monoclonal Antibodies
1.2.3 Immunomodulator
1.2.4 Other
1.3 Market by Application
1.3.1 Global Immune Cell Therapy Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Stomach Cancer
1.3.3 lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophageal Cancer
1.3.6 Pancreatic Cancer
1.3.7 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immune Cell Therapy Drugs Market Perspective (2018-2029)
2.2 Immune Cell Therapy Drugs Growth Trends by Region
2.2.1 Global Immune Cell Therapy Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Immune Cell Therapy Drugs Historic Market Size by Region (2018-2024)
2.2.3 Immune Cell Therapy Drugs Forecasted Market Size by Region (2024-2029)
2.3 Immune Cell Therapy Drugs Market Dynamics
2.3.1 Immune Cell Therapy Drugs Industry Trends
2.3.2 Immune Cell Therapy Drugs Market Drivers
2.3.3 Immune Cell Therapy Drugs Market Challenges
2.3.4 Immune Cell Therapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immune Cell Therapy Drugs Players by Revenue
3.1.1 Global Top Immune Cell Therapy Drugs Players by Revenue (2018-2024)
3.1.2 Global Immune Cell Therapy Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Immune Cell Therapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immune Cell Therapy Drugs Revenue
3.4 Global Immune Cell Therapy Drugs Market Concentration Ratio
3.4.1 Global Immune Cell Therapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immune Cell Therapy Drugs Revenue in 2022
3.5 Immune Cell Therapy Drugs Key Players Head office and Area Served
3.6 Key Players Immune Cell Therapy Drugs Product Solution and Service
3.7 Date of Enter into Immune Cell Therapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immune Cell Therapy Drugs Breakdown Data by Type
4.1 Global Immune Cell Therapy Drugs Historic Market Size by Type (2018-2024)
4.2 Global Immune Cell Therapy Drugs Forecasted Market Size by Type (2024-2029)
5 Immune Cell Therapy Drugs Breakdown Data by Application
5.1 Global Immune Cell Therapy Drugs Historic Market Size by Application (2018-2024)
5.2 Global Immune Cell Therapy Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Immune Cell Therapy Drugs Market Size (2018-2029)
6.2 North America Immune Cell Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Immune Cell Therapy Drugs Market Size by Country (2018-2024)
6.4 North America Immune Cell Therapy Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immune Cell Therapy Drugs Market Size (2018-2029)
7.2 Europe Immune Cell Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Immune Cell Therapy Drugs Market Size by Country (2018-2024)
7.4 Europe Immune Cell Therapy Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immune Cell Therapy Drugs Market Size (2018-2029)
8.2 Asia-Pacific Immune Cell Therapy Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2018-2024)
8.4 Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immune Cell Therapy Drugs Market Size (2018-2029)
9.2 Latin America Immune Cell Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Immune Cell Therapy Drugs Market Size by Country (2018-2024)
9.4 Latin America Immune Cell Therapy Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immune Cell Therapy Drugs Market Size (2018-2029)
10.2 Middle East & Africa Immune Cell Therapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2018-2024)
10.4 Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Detail
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Immune Cell Therapy Drugs Introduction
11.1.4 Aquila BioMedical Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.1.5 Aquila BioMedical Recent Development
11.2 BPS Bioscience
11.2.1 BPS Bioscience Company Detail
11.2.2 BPS Bioscience Business Overview
11.2.3 BPS Bioscience Immune Cell Therapy Drugs Introduction
11.2.4 BPS Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.2.5 BPS Bioscience Recent Development
11.3 Celentyx
11.3.1 Celentyx Company Detail
11.3.2 Celentyx Business Overview
11.3.3 Celentyx Immune Cell Therapy Drugs Introduction
11.3.4 Celentyx Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.3.5 Celentyx Recent Development
11.4 Crown Bioscience
11.4.1 Crown Bioscience Company Detail
11.4.2 Crown Bioscience Business Overview
11.4.3 Crown Bioscience Immune Cell Therapy Drugs Introduction
11.4.4 Crown Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.4.5 Crown Bioscience Recent Development
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Detail
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Introduction
11.5.4 DiscoverX Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.5.5 DiscoverX Corporation Recent Development
11.6 Explicyte
11.6.1 Explicyte Company Detail
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Immune Cell Therapy Drugs Introduction
11.6.4 Explicyte Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.6.5 Explicyte Recent Development
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Detail
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Introduction
11.7.4 Genscript Biotech Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.7.5 Genscript Biotech Corporation Recent Development
11.8 HD Biosciences
11.8.1 HD Biosciences Company Detail
11.8.2 HD Biosciences Business Overview
11.8.3 HD Biosciences Immune Cell Therapy Drugs Introduction
11.8.4 HD Biosciences Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.8.5 HD Biosciences Recent Development
11.9 Horizon Discovery Group
11.9.1 Horizon Discovery Group Company Detail
11.9.2 Horizon Discovery Group Business Overview
11.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Introduction
11.9.4 Horizon Discovery Group Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.9.5 Horizon Discovery Group Recent Development
11.10 ImmunXperts
11.10.1 ImmunXperts Company Detail
11.10.2 ImmunXperts Business Overview
11.10.3 ImmunXperts Immune Cell Therapy Drugs Introduction
11.10.4 ImmunXperts Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.10.5 ImmunXperts Recent Development
11.11 Molecular Imaging
11.11.1 Molecular Imaging Company Detail
11.11.2 Molecular Imaging Business Overview
11.11.3 Molecular Imaging Immune Cell Therapy Drugs Introduction
11.11.4 Molecular Imaging Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.11.5 Molecular Imaging Recent Development
11.12 Promega Corporation,Personalis
11.12.1 Promega Corporation,Personalis Company Detail
11.12.2 Promega Corporation,Personalis Business Overview
11.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Introduction
11.12.4 Promega Corporation,Personalis Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.12.5 Promega Corporation,Personalis Recent Development
11.13 STC Biologics
11.13.1 STC Biologics Company Detail
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Immune Cell Therapy Drugs Introduction
11.13.4 STC Biologics Revenue in Immune Cell Therapy Drugs Business (2018-2024)
11.13.5 STC Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immune Cell Therapy Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Immunomodulator
Table 4. Key Players of Other
Table 5. Global Immune Cell Therapy Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Immune Cell Therapy Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Immune Cell Therapy Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global Immune Cell Therapy Drugs Market Share by Region (2018-2024)
Table 9. Global Immune Cell Therapy Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Immune Cell Therapy Drugs Market Share by Region (2024-2029)
Table 11. Immune Cell Therapy Drugs Market Trends
Table 12. Immune Cell Therapy Drugs Market Drivers
Table 13. Immune Cell Therapy Drugs Market Challenges
Table 14. Immune Cell Therapy Drugs Market Restraints
Table 15. Global Immune Cell Therapy Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global Immune Cell Therapy Drugs Market Share by Players (2018-2024)
Table 17. Global Top Immune Cell Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2022)
Table 18. Ranking of Global Top Immune Cell Therapy Drugs Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Immune Cell Therapy Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Immune Cell Therapy Drugs Product Solution and Service
Table 22. Date of Enter into Immune Cell Therapy Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Immune Cell Therapy Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global Immune Cell Therapy Drugs Revenue Market Share by Type (2018-2024)
Table 26. Global Immune Cell Therapy Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Immune Cell Therapy Drugs Revenue Market Share by Type (2024-2029)
Table 28. Global Immune Cell Therapy Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global Immune Cell Therapy Drugs Revenue Market Share by Application (2018-2024)
Table 30. Global Immune Cell Therapy Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Immune Cell Therapy Drugs Revenue Market Share by Application (2024-2029)
Table 32. North America Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Immune Cell Therapy Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific Immune Cell Therapy Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Immune Cell Therapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa Immune Cell Therapy Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 47. Aquila BioMedical Company Detail
Table 48. Aquila BioMedical Business Overview
Table 49. Aquila BioMedical Immune Cell Therapy Drugs Product
Table 50. Aquila BioMedical Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 51. Aquila BioMedical Recent Development
Table 52. BPS Bioscience Company Detail
Table 53. BPS Bioscience Business Overview
Table 54. BPS Bioscience Immune Cell Therapy Drugs Product
Table 55. BPS Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 56. BPS Bioscience Recent Development
Table 57. Celentyx Company Detail
Table 58. Celentyx Business Overview
Table 59. Celentyx Immune Cell Therapy Drugs Product
Table 60. Celentyx Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 61. Celentyx Recent Development
Table 62. Crown Bioscience Company Detail
Table 63. Crown Bioscience Business Overview
Table 64. Crown Bioscience Immune Cell Therapy Drugs Product
Table 65. Crown Bioscience Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 66. Crown Bioscience Recent Development
Table 67. DiscoverX Corporation Company Detail
Table 68. DiscoverX Corporation Business Overview
Table 69. DiscoverX Corporation Immune Cell Therapy Drugs Product
Table 70. DiscoverX Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 71. DiscoverX Corporation Recent Development
Table 72. Explicyte Company Detail
Table 73. Explicyte Business Overview
Table 74. Explicyte Immune Cell Therapy Drugs Product
Table 75. Explicyte Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 76. Explicyte Recent Development
Table 77. Genscript Biotech Corporation Company Detail
Table 78. Genscript Biotech Corporation Business Overview
Table 79. Genscript Biotech Corporation Immune Cell Therapy Drugs Product
Table 80. Genscript Biotech Corporation Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 81. Genscript Biotech Corporation Recent Development
Table 82. HD Biosciences Company Detail
Table 83. HD Biosciences Business Overview
Table 84. HD Biosciences Immune Cell Therapy Drugs Product
Table 85. HD Biosciences Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 86. HD Biosciences Recent Development
Table 87. Horizon Discovery Group Company Detail
Table 88. Horizon Discovery Group Business Overview
Table 89. Horizon Discovery Group Immune Cell Therapy Drugs Product
Table 90. Horizon Discovery Group Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 91. Horizon Discovery Group Recent Development
Table 92. ImmunXperts Company Detail
Table 93. ImmunXperts Business Overview
Table 94. ImmunXperts Immune Cell Therapy Drugs Product
Table 95. ImmunXperts Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 96. ImmunXperts Recent Development
Table 97. Molecular Imaging Company Detail
Table 98. Molecular Imaging Business Overview
Table 99. Molecular Imaging Immune Cell Therapy Drugs Product
Table 100. Molecular Imaging Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 101. Molecular Imaging Recent Development
Table 102. Promega Corporation,Personalis Company Detail
Table 103. Promega Corporation,Personalis Business Overview
Table 104. Promega Corporation,Personalis Immune Cell Therapy Drugs Product
Table 105. Promega Corporation,Personalis Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 106. Promega Corporation,Personalis Recent Development
Table 107. STC Biologics Company Detail
Table 108. STC Biologics Business Overview
Table 109. STC Biologics Immune Cell Therapy Drugs Product
Table 110. STC Biologics Revenue in Immune Cell Therapy Drugs Business (2018-2024) & (US$ Million)
Table 111. STC Biologics Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immune Cell Therapy Drugs Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Immune Cell Therapy Drugs Market Share by Type: 2022 VS 2029
Figure 3. Monoclonal Antibodies Features
Figure 4. Immunomodulator Features
Figure 5. Other Features
Figure 6. Global Immune Cell Therapy Drugs Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 7. Global Immune Cell Therapy Drugs Market Share by Application: 2022 VS 2029
Figure 8. Stomach Cancer Case Studies
Figure 9. lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Esophageal Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Other Case Studies
Figure 14. Immune Cell Therapy Drugs Report Years Considered
Figure 15. Global Immune Cell Therapy Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Immune Cell Therapy Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Immune Cell Therapy Drugs Market Share by Region: 2022 VS 2029
Figure 18. Global Immune Cell Therapy Drugs Market Share by Players in 2022
Figure 19. Global Top Immune Cell Therapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immune Cell Therapy Drugs as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Immune Cell Therapy Drugs Revenue in 2022
Figure 21. North America Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 23. United States Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 27. Germany Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Asia-Pacific Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Asia-Pacific Immune Cell Therapy Drugs Market Share by Region (2018-2029)
Figure 35. China Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Japan Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. South Korea Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Southeast Asia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. India Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Australia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Latin America Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Latin America Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 43. Mexico Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Brazil Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East & Africa Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East & Africa Immune Cell Therapy Drugs Market Share by Country (2018-2029)
Figure 47. Turkey Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Saudi Arabia Immune Cell Therapy Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Aquila BioMedical Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 50. BPS Bioscience Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 51. Celentyx Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 52. Crown Bioscience Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 53. DiscoverX Corporation Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 54. Explicyte Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 55. Genscript Biotech Corporation Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 56. HD Biosciences Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 57. Horizon Discovery Group Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 58. ImmunXperts Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 59. Molecular Imaging Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 60. Promega Corporation,Personalis Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 61. STC Biologics Revenue Growth Rate in Immune Cell Therapy Drugs Business (2018-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed